COMPLIMENTARY EDUCATIONAL DVD AVAILABLE ON
“Preventing Recurrence of Breast Cancer ”
with Dr. Kathleen I. Pritchard, MD FRCPC, Head of Clinical Trials & Epidemiology, Toronto Sunnybrook Regional Cancer Centre and Professor, Departments of Medicine & Public Health Sciences, Faculty of Medicine, University of Toronto

According to the National Cancer Institute of Canada more than twenty-one thousand women are diagnosed with breast cancer every year. Many women who survive breast cancer are not aware that they’re still at risk of recurrence even after five years in remission. But today, targeted treatments including biogenic agents and hormonal therapies are giving patients more hope than ever of staying cancer free.

“If primary care physicians have patients in their practice who have hormone receptor positive
disease and who are post menopausal that have completed or about to complete five years of
tamoxifen, even though there may be an interval since they completed treatment, they probably should be getting a medical oncology opinion about whether they’re candidates for an aromatase inhibitor”, says Kathleen Pritchard, MD, Head of Clinical Trials & Epidemiology at the Toronto Sunnybrook Regional Cancer Centre.